Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sarah E Scheuermann

5PUBLICATIONS

53CO-AUTHORS

Immunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Gene and molecular therapyBiological adaptationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 27, 2024

The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection.

Alexandra Melton, Lori A Rowe, Toni Penney

|Apr 27, 2024

Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in <i>Rag2</i><sup>-/-</sup> Mice.

Calder R Ellsworth, Chenxiao Wang, Alexis R Katz

|Sep 28, 2023

Real-Time Analysis of SARS-CoV-2-Induced Cytolysis Reveals Distinct Variant-Specific Replication Profiles.

Sarah E Scheuermann, Kelly Goff, Lori A Rowe

|Aug 17, 2022

Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.

Prabhu S Arunachalam, Yupeng Feng, Usama Ashraf

|May 14, 2021

Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge.

Addison E Stone, Sarah E Scheuermann, Colin N Haile

Pageof 1

Frequent Collaborators

4 joint publications

Nicholas J Maness

3 joint publications

Brandon J Beddingfield

2 joint publications

Robert V Blair

2 joint publications

Jay K Kolls

2 joint publications

Lori A Rowe

1 joint publications

Anantha L Duddupudi

1 joint publications

Marco Pravetoni

1 joint publications

Elizabeth B Norton

1 joint publications

Prabhu S Arunachalam

1 joint publications

Usama Ashraf

Frequent Collaborators

4 joint publications

Nicholas J Maness

3 joint publications

Brandon J Beddingfield

2 joint publications

Robert V Blair

2 joint publications

Jay K Kolls

Top Related Videos

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4<sup>+</sup> T Cells Isolated from Rhesus macaques

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4<sup>+</sup> T Cells Isolated from Rhesus macaques

Published on : Sep 25, 2018

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

See more related videos

Top Related Videos

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4<sup>+</sup> T Cells Isolated from Rhesus macaques

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4<sup>+</sup> T Cells Isolated from Rhesus macaques

Published on : Sep 25, 2018

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

See more related videos